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Abstract
Background Bone grafting is used to enhance healing in
osteotomies, arthrodesis, and multifragmentary fractures
and to replace bony loss resulting from neoplasia or cysts.
They are source of osteoprogenitor cells and induce bone
formation and provide mechanical support for vascular and
bone ingrowth. Autografts are used commonly but quantity
of harvested bone is limited. The aim of this study is to
evaluate autograft and new xenogenic bovine demineral-
ized bone matrix (DBM) effects on bone healing process.
Materials and methods Twenty male White New Zealand
rabbits were used in this study. In group I (n = 10) the
defect was ﬁlled by xenogenic DBM and in autograft group
the defect was ﬁlled by fresh autogenous cortical graft and
ﬁxed by cercelage wire. Radiological, histopathological
and biomechanical evaluations were performed blindly and
results scored and analyzed statistically.
Results Statistical tests did not reveal any signiﬁcant
differences between two groups on the 14th postoperative
day radiographically (P[0.05). There was a signiﬁcant
difference for union on 28th and 42nd postoperative days
and for remodeling at on the 56th postoperative day
radiologically (P\0.05). Statistical tests did not support
any signiﬁcant differences between two groups for radio-
logical bone formation (P[0.05). Histopathological and
biomechanical evaluation revealed no signiﬁcant differ-
ences between two groups.
Conclusions The results of this study indicate that satis-
factory healing occurred in rabbit radius defect ﬁlled with
xenogenic bovine DBM. Complications were not identiﬁed
and healing was faster, same as in cortical autogenous
grafting.
Keywords Xenogenic DBM  Autogenous cortical bone 
Bone healing  Rabbit
Introduction
Bone grafting is used to enhance healing in delayed
unions, nonunions, ostoectomies, arthrodesis, multifrag-
mentary fractures and to replace bony loss resulting from
neoplasia or cysts [1]. Autogenous bone graft is commonly
used and is the standard to which allografts and graft
substitutes are compared [2–7]. They may provide
a source of osteoprogenitor cells (osteogenesis), induce
formation of osteoprogenitor cells from surrounding tis-
sues (osteoinduction), and provide mechanical support
for vascular and bone ingrowth (osteoconduction) [8].
Though autogenous bone grafts have been clinically
effective, the additional surgical time required to harvest
an autogenous graft, the morbidity associated with its
collection, and the limited availability of autogenous bone
in some patients, have encouraged the search of suitable
bone graft substitutes [5, 9–11]. Therefore, the use of
various bone graft substitutes including autografts, allo-
grafts, xenografts, polymers, ceramics and some metals
have been employed to promote bone reunion [12, 13].
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used for several decades in human surgery for the treat-
ment of nonunions, osteomyelitis and large defects
resulting from benign tumor removal [14]. The process of
demineralization with hydrochloric acid destroys, but also
decreases antigenic stimulation and may enhance the
release of bone morphogenic protein (BMP) [15]. BMPs
stimulate local undifferentiated mesenchymal cells to
transform into osteoblasts (osteoinduction), and the col-
lagenous framework of the DBM particles allows for
migration of tissue into the site (osteoconduction).
Extensive research continues to identify the different
BMPs that might be osteoinductive, and these are being
readied for clinical application [16–19]. Beyond their role
in osteoinduction, certain BMPs and DBM have shown
promise in aiding repair of osteochondral defects [20, 21].
Advantages of DBM over other substitutes include inher-
ent osteoinductive capacity (unlike tricalcium phosphate
and hydroxyapatite) and availability in large amounts. The
aim of study reported here was to compare the effects of
xenogenic bovine DBM and fresh cortical autogenous
bone on the healing of bone defects in rabbits.
Materials and methods
Animals
Twenty male New Zealand Albino rabbits 12 months old
and weighing 3.0 ± 0.5 kg were used in this study. The
research protocol for this experiment was approved by the
Shiraz University research committee.
Preparation of bovine demineralized bone matrix
Demineralized bone matrix, prepared from the midshafts of
the long bones of a 2-year-old Holstein cow, were collected
from the local slaughterhouse. All bones were collected
aseptically, and the soft tissues were removed before
storage at -70C. The bones were later cleared of fascia
and cut into 1-cm pieces with a Stryker saw under saline
(0.9% NaCl) solution lavage. Bone pieces were stored at
-70C until further use. The pieces were then thawed in
200-proof ethanol and air-dried. All bones were milled
(Universal Mill A-20; Tekmer Co, Cincinnati, OH, USA)
and placed through a sieve to collect 2- to 4-mm pieces.
The pieces were then decalciﬁed in 0.6 mol/l HCL at 4C
for 8 days under constant agitation.
Demineralization was evaluated with radiography and
calcium analysis [22]. Density loss of xenogenic demin-
eralized bone matrix was evaluated radiographically. Also,
random samples of DBM were dried at 95C, weighed,
and then ashed at 600C for 24 h. These samples were
then dissolved in 0.6 mol/l nitric acid and analyzed by
atomic absorption spectrophotometry to determine percent
calcium per gram dry weight (% Ca:DW) [23, 24].
Demineralization was considered adequate when samples
were no longer visible radiographically and when calcium
content was less than 1% [25]. After demineralization, all
bone pieces were rinsed in sterile water and placed in
phosphate buffer overnight. The bone pieces were then
rinsed and the pH was adjusted to 7.3. They were placed
in ethanol, the ethanol was allowed to evaporate overnight,
and the pieces were packaged aseptically and stored at
4C.
Preparation of fresh cortical autogenous bone graft
Fresh autogenous cortical bone was harvested at the time of
surgery during the creation of radius bone defect. Then all
soft tissues were removed from the harvested bone and
used as a fresh autogenous cortical bone graft.
Surgical technique
Animals were anaesthetized with ketamine (40 mg/kg, IM)
and xylazine (5 mg/kg, IM). The left forelimb was shaved
and prepared aseptically with povidone iodine and the limb
draped with sterile drapes. An incision was made directly
over the radius; which was exposed by dissection of
surrounding muscles. Then an osteoperiosteal segmental
defect was created on the middle portion of each radius at
least twice as long as the diameter of the diaphysis for
creation of nonunion model [26]. The created defects were
ﬁlled in ten rabbits (group I) with DBM (20 mg/defect) and
in other ten rabbits (group II) with same harvested segment
of cortical bone and ﬁxed by cercelage wire for prevention
of segment dislocation in the grafted area.
Postoperative evaluation
Radiological evaluation
Radiographs of each forelimb were taken postoperatively
on 1st day and at the 2nd, 4th, 6th and 8th weeks to
evaluate bone formation, union and remodeling of the
defect. Results were scored using a modiﬁed Lane and
Sandhu scoring system [27] (Table 1).
Histopathological evaluation
Eight weeks after operation the rabbits were euthanized
pharmacologically for histopathological and biomechanical
evaluation. Histopathological evaluation was carried out on
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123ﬁve rabbits of each group randomly. Left forelimb were
harvested and dissected free of soft tissues. Sagittal sections
that contained the defect site were cut with a slow-speed
saw. Each slice was then ﬁxed in 10% formalin. The for-
malin-ﬁxed bone samples were decalciﬁed in 15% buffered
formic acid solution and processed for routine histological
examination. Two 5-micron thick sections were cut from
the centers of each specimen and were stained with hema-
toxylin and eosin. The sections were individually evaluated
and scored by pathologist blinded to the treatment. Scoring
system was according to lane and Sandhu modiﬁed scoring
system by Hieple et al 1987 (Table 2)[ 28].
Biomechanical evaluation
Mechanical bending test was performed on radial-healed
defect of the left forelimb of ﬁve rabbits of each group by
biomechanical testing machine (Shimatzo, Japan). During
the test, the bone ends were placed between two jaws in the
testing machine and the load exerted at the grafting area
until the failure. The forces, which were needed to break
the bones were recorded. Data derived from mechanical
testing were expressed as the mean ± SEM (standard error
mean) for each group.
Statistical analysis
The radiological and histopathological data were compared
by Kruskal–Wallis, non-parametric ANOVA, when P-val-
ues were found to be less than 0.05, then pair wise group
comparisons were performed by Mann–Whitney U test. The
biomechanical data was compared by a Student’s t-test
(SPSS 15.00).
Results
There was no intraoperative and postoperative death during
the study. None of the rabbits sustained a fracture of the
radius.
Radiographic ﬁndings
There was 25% bone formation in some rabbits in group I
and group II on 14th postoperative day. Although there was
union in some rabbits of group I, there was no evidence of
union in group II. Remodeling was not found in either
group. Statistical tests did not support any signiﬁcant
difference (Table 3, P[0.05) (Fig. 1).
There was 50–75% bone formation in some rabbits of
group I and 0–25% bone formation in some rabbits of group
IIon28thpostoperativeday.Althoughtherewassomeunion
Table 1 Modiﬁed Lane and Sandhu radiological scoring system
Bone formation
No evidence of bone formation 0
Bone formation occupying 25% of defect 1
Bone formation occupying 50% of defect 2
Bone formation occupying 75% of defect 3
Bone formation occupying 100% of defect 4
Union (proximal and distal evaluated separately)
Nonunion 0
Possible union 1
Radiographic union 2
Total point possible per category
Bone formation 4
Proximal union 2
Distal union 2
Remodeling 2
Maximum Score 10
Table 2 Lane and Sandhu histopathological scoring system modiﬁed
by Heiple et al. [28]
Union (proximal and distal evaluated separately)
No evidence of union 0
Fibrous union 1
Osteochondral union 2
Bone union 3
Complete organization of shaft 4
Cancellous bone
No osseous cellular activity 0
Early apposition of new bone 1
Active apposition of new bone 2
Reorganizing cancellous bone 3
Complete reorganization of cancellous bone 4
Cortical bone
Non 0
Early appearance 1
Formation under way 2
Mostly reorganized 2
Completely formed 10
Marrow
None is resected area 0
Beginning to appear 1
Present in more than half of the defect 2
Complete colonization by red marrow 3
Mature fatty marrow 4
Total points possible per category
Proximal union 4
Distal union 4
Cancellous bone 4
Cortex 4
Marrow 4
Maximum score 20
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123in most rabbits of group II, remodeling was not seen in all
rabbits of either groups. There was a statistically signiﬁcant
difference onlyforunion atthe28thpostoperative dayinthe
radiological signs of bone healing (P\0.05). When pair-
wise group comparisons were performed by Mann–Whitney
U test, group II was found to be superior to group I (Table 4,
P = 0.008 and P = 0.03) (Fig. 2).
There was 75–100% bone formation in all rabbits in
group I and 50–75% bone formation in all rabbits of group
II on 42nd postoperative day. Although there was some
union in all rabbits of both groups and some remodeling in
group I. There was a statistically signiﬁcant difference only
for union at the 42nd postoperative day in the radiological
signs of bone healing (P\0.05). When pairwise group
comparisons were performed by Mann–Whitney U test,
group II was found to be superior to group I (Table 5,
P = 0.01) (Fig. 3).
There was 100% bone formation and union in group I
and 75–100% bone formation and some union in group II
on 56th postoperative day. There were 25–50% points
remodeling in the two groups. Group II was statistically
superior to group I only in terms of radiological callus
remodeling (P\0.05). When pairwise group comparisons
were performed with Mann–Whitney U test, the group II
was superior to group I (Table 6, P\0.03) (Fig. 4).
Histopathological ﬁndings
Histopathologically there was no statistically signiﬁcant
difference between the groups in terms of cancellous and
cortical bone, union and marrow formation. None of the
grafted materials elicited a signiﬁcant inﬂammatory reac-
tion. In the group II the chondroblastic differentiation zone
was observed (Table 7, P[0.05) (Fig. 5).
Biomechanical ﬁndings
There was no statistically signiﬁcant difference between
two groups in terms of biomechanical bending test
(Table 8, P[0.05).
Table 3 Radiological ﬁndings
at 2nd week
a Kruskal–Wallis non-
parametric ANOVA
Median (min–max) P
a
Group I (n = 10) Group II (n = 10)
Bone formation 0 (0–0) 0 (0–1) 0.11
Proximal union 0 (0–0) 0 (0–1) 0.36
Distal union 0 (0–0) 0 (0–0) 1.000
Remodeling 0 (0–0) 0 (0–0) 1.000
Fig. 1 Radiographs of forelimb
on 14th postoperative day.
(a Xenogenic DBM.
b autograft)
Table 4 Radiological ﬁndings at 4th week
Median (min–max) P
a
Group I (n = 10) Group II (n = 10)
Bone formation 1 (1–1) 1 (1–1) 0.006
Proximal union 0 (0–0) 1 (1–1)
b 0.004
Distal union 0 (0–0) 1 (0–1)
c 0.006
Remodeling 0 (0–0) 0 (0–0) 1.000
Signiﬁcant P-values are presented in bold face
a Kruskal–Wallis non-parametric ANOVA
b P = 0.008 (compared with group I by Mann–Whitney U test)
c P = 0.03 (compared with group I by Mann–Whitney U test)
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In this study a radius defect model was created to
compare healing of bovine DBM implant as a new
xenograft and fresh autogenous cortical bone graft in the
rabbit model. This model has been reported previously
suitable because there was no need for internal or
external ﬁxation that can inﬂuence the healing process
[29]. The osteoperiosteal segemental defect was created
in middle portion of radius at least twice as long as the
diameter of diaphysis to produce nonunion model and
prevent spontaneous healing [26].
Fig. 2 Radiographs of forelimb
on 28th postoperative day.
(a Xenogenic DBM,
b autograft)
Table 5 Radiological ﬁndings at 6th week
Median (min–max) P
a
Group I (n = 10) Group II (n = 10)
Bone formation 2 (1–3) 2 (1–2) 0.11
Proximal union 1 (0–1) 2 (1–2)
b 0.008
Distal union 1 (0–1) 2 (1–2) 0.01
Remodeling 1 (0–1) 1 (0–1) 0.17
Signiﬁcant P values are presented in bold face
a Kruskal–Wallis non-parametric ANOVA
b P = 0.01 (compared with group I by Mann–Whitney U test)
Fig. 3 Radiographs of forelimb
on 42nd postoperative day.
(a Xenogenic DBM,
b autograft)
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on 56th postoperative day.
(a Xenogenic DBM,
b autograft)
Table 7 Histopathological
ﬁndings at 8th week
a Kruskal–Wallis non-
parametric ANOVA
Median (min–max) P
a
Group I (n = 5) Group II (n = 5)
Union 2 (1–2) 1 (1–2) 0.2
Cortical bone 1 (0–3) 1 (0–2) 0.9
Cancellous bone 1 (1–3) 1 (0–3) 0.6
Bone marrow 1 (0–2) 1 (0–2) 1.000
Fig. 5 Histopathological
evaluation of a Xenogenic
DBM implantation. Note the
chondroblastic differentiation in
grafted area (white arrow)
(H&E 9 100) and b cortical
bone autograft
Table 6 Radiological ﬁndings at 8th week
Median (min–max) P
a
Group I (n = 10) Group II (n = 10)
Bone formation 2 (0–3) 2 (1–3) 0.13
Proximal union 1 (0–2) 2 (1–2) 0.9
Distal union 1 (0–2) 1 (1–2) 0.1
Remodeling 1 (1–1) 1 (0–2)
b 0.007
Signiﬁcant P-values are presented in bold face
a Kruskal–Wallis non-parametric ANOVA
b P = 0.03 (compared with group I by Mann–Whitney U test)
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established [30–38]. The addition of autologous bone
marrow and/or autograft to DBM provides an immediate
source of osteogenic precursor cells at the implant site that
may provide an additional biochemical contribution to
osteogenesis [37–39]. DBM also appears to support new
bone formation through osteoconductive mechanisms [40].
Autogenous bone graft is commonly used and is the stan-
dard, to which allografts and graft substitute are compared
[2–7]. The primary osteoinductive component of DBM is a
series of low-molecular-weight glycoproteins that includes
the BMPs. The decalciﬁcation of cortical bone exposes
these osteoinductive growth factors buried within the
mineralized matrix, thereby enhancing the bone formation
process [41]. These proteins promote the chondroblastic
differentiation of mesenchymal cells, followed with new
bone synthesis by endochondral osteogenesis [41, 42]. In
this study, it was found that the results of group I was not
statistically signiﬁcant after the 8 weeks in comparison
with group II. It proves that the grafted xenogenic bovine
DBM has osteoinductive (by releasing the some BMPs)
activity same as autogenous cortical bone graft. However it
was found that cortical autograft has more osteoconductive
properties and less osteoinductive activity [43, 44]. DBM
also appears to support new bone formation through
osteoconductive mechanisms [40]. There were not any
signiﬁcant differences in histopathological evaluation
between two groups and none of the graft material elicited
a signiﬁcant inﬂammatory reaction. It has been reported
that the demineralization process destroys the antigenic
materials in bone, making DBM less immunogenic than
mineralized allograft [45] and the cortical autogenous bone
graft does not induce immunological reaction by the host
[43]. Therefore, we did not observe any inﬂammatory
reaction in group I and group II. We observed chondrob-
lastic differentiation zone in histopathological evaluation
of group I. Urist showed chondroblastic differentiation
from mesenchymal cell by bone morphogenetic proteins
[41, 42]. It was understood that the chondroblastic differ-
entiation in group I was related to BMPs releasing from
grafted bovine DMB.
In biomechanical evaluation, group I was superior to
group II, but there is not any statistically signiﬁcant dif-
ference between two groups. It has been reported that
cortical autogenous bone graft remains a combination of
necrotic and new bone for a prolonged period and leads to
reduction in mechanical strength [46]. Moreover, experi-
mental studies have shown that osteoinductive bone protein
growth factors combined with DBM produce biomechani-
cally enhanced fusions as compared to autograft alone
[47–50]. A number of well-controlled studies in a well-
established and validated animal model of posterolateral
spine fusion have demonstrated the suitability of various
forms of DBM as a graft extender and, in some cases, as a
graft enhancer and a graft substitute [40, 51]. The results of
this study indicate that satisfactory healing occurred in
rabbit radius defect ﬁlled with xenogenic bovine DBM.
Complications were not identiﬁed and healing was faster,
same as in cortical autogenous grafting. The use of xeno-
genic bovine DBM is an acceptable alternative to cortical
autogenous graft and could reduce the morbidity associated
with harvesting autogenous graft during surgery. Further
studies are needed to evaluate the long-term effects of
DBM implantation on bone healing to document the use of
this graft substitute in various clinical situations. DBM has
a number of additional advantages that make it an attrac-
tive bone graft alternative. It is cost-effective and is readily
available from tissue banks.
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